Evaluation of anti-AIDS drugs in conventional mice implanted with a permeable membrane device containing human T cells infected with HIV

Antiviral Research

Volumn 35, Issue 2, 1997, Pages 123-129

  Quenelle, Debra C ^a   Keith, Kathy A ^a   Dunleavy, Karen E ^b   Taylor, Beth A ^a   Bowdon, Bonnie J ^a   Brazier, Anne D ^a   Mullon, Claudy J P ^b   Harris, Reginald E ^a   Allen, Lois B ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b W R GRACE AND CO CONN   (United States)

Author keywords

AIDS drug evaluation; HIV animal model; Hollow fibers

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIGEN P24; CD4 ANTIGEN; RNA DIRECTED DNA POLYMERASE; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEVICE; HOLLOW FIBER MEMBRANE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPLANTATION; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERITONEAL CAVITY; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; VIRUS STRAIN;

ANIMALIA; HIV 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031005301     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)00014-4     Document Type: Article

References (11)

1. Altman, J., Houlbert, D., Callard, P., McMillan, P., Solomon, B., Galetti, P., 1988. Long-term plasma glucose normalization in experimental diabetic rats with macroencapsulated implants of benign human insulinomas. Diabetes 35, 625-633.
2. Hollingshead, M., Roberson, J., Decker, W., Buckheit, R., Elder, C., Malspeis, L., Mayo, J., Grever, M., 1995. In vivo drug screening applications of HIV-infected cells cultivated within hollow fibers in two physiologic compartments of mice. Antiviral Res. 28, 265-279.
3. Hosoi, S., 1990. Bursos, T., Dunlop, N., Nara, P.L. Heat-labile, complement-like factor(s) of animal sera prevent(s) HIV infectivity in vitro. J. Acquired Immune Deficiency Syndromes 3, 366-371.
4. Lanza, R., Butler, D., Borland, K., Staruk, J., Faustman, D., Solomon, G., Muller, T., Rupp, R., Maki, T., Monaco, A., Chick, W., 1991. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc. Natl. Acad. Sci. 88, 1100-1104.
5. Lanza, R., Sullivan, S., Chic, W., 1992. Islet transplantation with immunoisolation. Diabetes 41, 1503-1560.
6. Maki, T., Ubhi, C., Sanchez-Farpon, H., Sullivan, S., Borland, K., Muller, T., Solomon, B., Chick, W., Monaco, A., 1991. Successful treatment of diabetes with the biohybrid artificial pancreas in dogs. Transplantation 51, 43-51.
7. Maki, T., Mullon, C., Solomon, B., Monaco, A., 1995. Novel delivery of pancreatic islet cells to treat insulin-dependent Diabetes Mellitus. Clin. Pharmacokinet. 28 (6), 471-481.
8. Maki, T., Otsu, I., O'Neil, J., Dunleavy, K., Mullon, C., Solomon, B., Monaco, A., 1996. Treatment of diabetes by xenogeneic islets without immunosuppression - use of a vascularized bioartificial pancreas. Diabetes 45, 342-347.
9. Michaels, A., 1971. U.S. Patent 3615024.
10. Shoichet, M., Rein, D., 1996. In vivo biostability of a polymeric hollow fiber membrane for cell encapsulation. Biomaterials 17, 285-290.
11. Sullivan, S., Maki, T., Borland, K., Mahoney, M., Solomon, B., Muller, T., Monaco, A., Chick, W., 1991. Biohybrid artificial pancreas: long-term implantation studies in diabetic pancreatectomized dogs. Science 252, 718-721.